Forskning ved Københavns Universitet - Københavns Universitet

Forside

Rational design of antisense oligonucleotides targeting single nucleotide polymorphisms for potent and allele selective suppression of mutant Huntingtin in the CNS

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Michael E Østergaard
  • Amber L Southwell
  • Holly Kordasiewicz
  • Andrew T Watt
  • Skotte, Niels
  • Crystal N Doty
  • Kuljeet Vaid
  • Villanueva, Erika
  • Eric E Swayze
  • C Frank Bennett
  • Michael R Hayden
  • Punit P Seth

Autosomal dominant diseases such as Huntington's disease (HD) are caused by a gain of function mutant protein and/or RNA. An ideal treatment for these diseases is to selectively suppress expression of the mutant allele while preserving expression of the wild-type variant. RNase H active antisense oligonucleotides (ASOs) or small interfering RNAs can achieve allele selective suppression of gene expression by targeting single nucleotide polymorphisms (SNPs) associated with the repeat expansion. ASOs have been previously shown to discriminate single nucleotide changes in targeted RNAs with ∼5-fold selectivity. Based on RNase H enzymology, we enhanced single nucleotide discrimination by positional incorporation of chemical modifications within the oligonucleotide to limit RNase H cleavage of the non-targeted transcript. The resulting oligonucleotides demonstrate >100-fold discrimination for a single nucleotide change at an SNP site in the disease causing huntingtin mRNA, in patient cells and in a completely humanized mouse model of HD. The modified ASOs were also well tolerated after injection into the central nervous system of wild-type animals, suggesting that their tolerability profile is suitable for advancement as potential allele-selective HD therapeutics. Our findings lay the foundation for efficient allele-selective downregulation of gene expression using ASOs-an outcome with broad application to HD and other dominant genetic disorders.

OriginalsprogEngelsk
TidsskriftNucleic Acids Research
Vol/bind41
Udgave nummer21
Sider (fra-til)9634-50
Antal sider17
ISSN0305-1048
DOI
StatusUdgivet - nov. 2013
Eksternt udgivetJa

ID: 153451258